Crossmark

Comparing the Clinical Outcomes Observed with Rivaroxaban Versus Warfarin for the Management of Obese Patients with Non-valvular Atrial Fibrillation: a Systematic Review and Meta-analysis

Crossref DOI link: https://doi.org/10.1007/s10557-022-07361-9

Published Online: 2022-06-28

Published Print: 2024-02

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Zhuo, Xiaojun

Wang, Jian

Shao, Lihui http://orcid.org/0000-0003-0735-9377
License Information

Text and Data Mining valid from 2022-06-28

Version of Record valid from 2022-06-28
More Information

Article History

Accepted: 15 June 2022

First Online: 28 June 2022

Declarations

:

: Ethical approval was not applicable for this systematic review and meta-analysis.

: Not applicable.

: The authors declare no competing interests.

: Xiaojun Zhuo is the first author of this manuscript.

Document is current

Any future updates will be listed below